Publications in collaboration with researchers from Hospital Clinic Barcelona (58)

2025

  1. Impact of PSMA-PET/CT on Radiotherapy Decisions: Is There a Clinical Benefit?

    Cancers, Vol. 17, Núm. 8

  2. Rehabilitation in patients with obesity: Approach and role of the rehabilitation physician in management. Data from the survey by the Obesity and Sarcopenia Working Group of the Spanish Society of Rehabilitation and Physical Medicine

    Rehabilitacion, Vol. 59, Núm. 1

2024

  1. Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study)

    Neuro-oncology, Vol. 26, Núm. 11, pp. 2074-2083

  2. National Diagnostic Reference Levels for Standard Descending Thoracic Endovascular Aortic Repair and Optimisation Strategies

    European Journal of Vascular and Endovascular Surgery, Vol. 68, Núm. 2, pp. 210-217

  3. What to Expect (and What Not) from Dual-Energy CT Imaging Now and in the Future?

    Journal of Imaging, Vol. 10, Núm. 7

2023

  1. Diffusion-weighted MRI for Diagnosing Extramural Venous Invasion in Rectal Cancer after Neoadjuvant Therapy: A Prognostic Biomarker

    Radiology

  2. Economic evaluations of radioembolization with yttrium-90 microspheres in liver metastases of colorectal cancer: a systematic review

    BMC Gastroenterology, Vol. 23, Núm. 1

  3. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

  4. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document

    Revista Espanola de Cardiologia, Vol. 76, Núm. 3, pp. 183-196

  5. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document

    Radiologia, Vol. 65, Núm. 3, pp. 269-284

  6. Maximal Respiratory Pressure Reference Equations in Healthy Adults and Cut-off Points for Defining Respiratory Muscle Weakness

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 813-820

2022

  1. Adaptation to tonic heat in healthy subjects and patients with sensory polyneuropathy

    European Journal of Pain (United Kingdom), Vol. 26, Núm. 5, pp. 1056-1068

  2. High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial

    The Lancet Oncology, Vol. 23, Núm. 5, pp. 671-681

  3. Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 11, pp. 1196-1205

  4. Stent-retriever alone versus combined use of stent-retriever and contact aspiration technique for middle cerebral artery M2 occlusions: a propensity score analysis

    Journal of neurointerventional surgery, Vol. 14, Núm. 11, pp. 1062-1067

  5. The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 2, pp. 126-135

2021

  1. 10-Year Results of a Phase III Randomized Trial of High-Dose Radiotherapy and Risk-Adapted Androgen Deprivation in Localized Prostate Cancer

    International journal of radiation oncology, biology, physics, Vol. 111, Núm. 3, pp. S77

  2. Brain and lung imaging correlation in patients with COVID-19: Could the severity of lung disease reflect the prevalence of acute abnormalities on neuroimaging? A global multicenter observational study

    American Journal of Neuroradiology, Vol. 42, Núm. 6, pp. 1008-1016

  3. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2749-2764

  4. Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial

    Radiotherapy and Oncology, Vol. 160, pp. 115-119